Lincomycin is a lincosamide antibacterial used for selected susceptible gram-positive, anaerobic and Mycoplasma infections. Veterinary applications include swine respiratory, joint and enteric disease and some companion-animal skin infections. Its spectrum and availability differ from those of clindamycin, the other commonly used veterinary lincosamide.
Group
Lincosamide antibacterial
Mechanism of Action
Lincomycin binds the 50S bacterial ribosomal subunit and inhibits peptide-chain elongation during protein synthesis. This usually produces bacteriostatic activity, with the effect determined by organism susceptibility and drug exposure. The binding region overlaps that of some macrolides and related agents. Its spectrum includes selected gram-positive organisms, mycoplasmas and susceptible enteric pathogens relevant to swine disease.
Dose Rates
Dogs
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 22 mg/kg | PO | Every 12 h | |
| Susceptible bacterial infection | 22 mg/kg | IV | Every 24 h | Administer slowly. |
| Susceptible bacterial infection | 11 mg/kg | IV | Every 12 h | Divided-dose alternative; administer slowly. |
| Skin and soft-tissue infection | 15.4 mg/kg | PO | Every 8 h | Superficial pyoderma courses 21-42 days; deep/resistant infection may require 56 days. |
| Superficial pyoderma | 20 mg/kg | PO | Every 12 h | |
| Susceptible bacterial infection | 22 mg/kg | IM, SC | Every 24 h | Up to 12 days |
| Susceptible bacterial infection | 11 mg/kg | IM, SC | Every 12 h | Up to 12 days |
| Bacteraemia or sepsis | 11–22 mg/kg | IV | Every 8 h | Up to 12 days; Dilute and infuse slowly. |
Cats
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 22 mg/kg | PO | Every 12 h | |
| Susceptible bacterial infection | 22 mg/kg | IV | Every 24 h | Administer slowly. |
| Susceptible bacterial infection | 11 mg/kg | IV | Every 12 h | Divided-dose alternative; administer slowly. |
| Skin and soft-tissue infection | 11 mg/kg | IM | Every 12 h | Up to 12 days |
| Skin and soft-tissue infection | 22 mg/kg | IM | Every 24 h | Up to 12 days |
| Systemic bacterial infection | 15 mg/kg | PO | Every 8 h | Up to 12 days |
Pigs
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Swine dysentery | Reference only | PO | 250 mg per gallon drinking water as the only water reported guidance for 5-10 days; reported guidance estimates about 8.4 mg/kg/day. Actual water intake controls exposure, so the estimate is not an exact universal dose. | |
| Mycoplasma infection | 11 mg/kg | IM | Every 24 h | Up to 7 days; Course 3-5 days. Separate 3-7-day source alternative. |
Cattle
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Historical septic arthritis, mastitis and abscess treatment | 5 mg/kg | IM | Every 24 h | Up to 7 days; Reported course 5-7 days; current monograph does not recommend routine use. |
| Historical refractory infection treatment | 10 mg/kg | IM | Every 12 h | Current monograph does not recommend routine use. |
Sheep
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Historical septic arthritis treatment | 5 mg/kg | IM | Every 24 h | Up to 5 days; Reported course 3-5 days; current monograph does not recommend routine use. |
Ferrets
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 10–15 mg/kg | PO | Every 8 h | |
| Susceptible bacterial infection | 10 mg/kg | IM | Every 12 h |
Indications
- Treatment of selected susceptible gram-positive skin and soft-tissue infections in dogs and cats.
- Treatment of susceptible mycoplasmal pneumonia or infectious arthritis in pigs with a corresponding product.
- Treatment or control of swine dysentery caused by susceptible Brachyspira hyodysenteriae.
- Treatment or control of porcine proliferative enteropathy associated with susceptible Lawsonia intracellularis.
- Treatment of selected poultry mycoplasmal infections within an indicated lincomycin-containing regimen.
Contraindications
- Oral use in horses, rabbits, rodents and ruminants can cause severe or fatal enteritis.
Interactions
- Cross-resistance with macrolides and clindamycin may occur.
Adverse effects
- Vomiting and diarrhoea
- Severe dysbiosis and enteritis in susceptible herbivores
Toxicity
Stop treatment for severe gastrointestinal reactions; assess hydration and enteritis.
Preparations
| Preparation | Form | Strength | Route |
|---|---|---|---|
| Lincomycin 100 mg tablet | Tablet | 100 mg / tablet | PO |
| Lincomycin 200 mg tablet | Tablet | 200 mg / tablet | PO |
| Lincomycin 500 mg tablet | Tablet | 500 mg / tablet | PO |
| Lincomycin 25 mg/mL injection | Injection | 25 mg / mL | IV, IM |
| Lincomycin 50 mg/mL injection | Injection | 50 mg / mL | IV, IM |
| Lincomycin 100 mg/mL injection | Injection | 100 mg / mL | IV, IM |
| Lincomycin 300 mg/mL injection | Injection | 300 mg / mL | IV, IM |
| Lincomycin 50 mg/mL oral drops | Oral Liquid | 50 mg / mL | PO |
Monitoring and Administration
Use susceptibility testing when feasible.
Give IV injections slowly. Source ruminant injection regimens are historical and the monograph states that these uses are not currently recommended.
Canine pyoderma alternative totals 40-50 mg/kg/day split into two or three doses; do not give the whole daily total at each administration. Swine feed medication is described as 200 g/ton for 21 days; actual feed intake and the ton definition must be established.